Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 24;23(1):773.
doi: 10.1186/s12877-023-04483-z.

Association between BMI trajectories in late-middle age and subsequent dementia risk in older age: a 26-year population-based cohort study

Affiliations

Association between BMI trajectories in late-middle age and subsequent dementia risk in older age: a 26-year population-based cohort study

Zijian Qin et al. BMC Geriatr. .

Abstract

Background: The association between body mass index (BMI) and dementia risk differs depending on follow-up time and age at BMI measurement. The relationship between BMI trajectories in late-middle age (50-65 years old) and the risk of dementia in older age (> 65 years old) has not been revealed.

Methods: In the present study, participants from the Health and Retirement Study were included. BMI trajectories were constructed by combining BMI trend and variation information. The association between BMI trajectories at the age of 50-65 years and dementia risk after the age of 65 years was investigated. Participants with European ancestry and information on polygenic scores for cognitive performance were pooled to examine whether genetic predisposition could modify the association.

Results: A total of 10,847 participants were included in the main analyses. A declining BMI trend and high variation in late-middle age were associated with the highest subsequent dementia risk in older age compared with an ascending BMI trend and low variation (RR = 1.76, 95% CI = 1.45-2.13). Specifically, in stratified analyses on BMI trajectories and dementia risk based on each individual's mean BMI, the strongest association between a declining BMI trend with high variation and elevated dementia risk was observed in normal BMI group (RR = 2.66, 95% CI = 1.72-4.1). Similar associations were found when participants were stratified by their genetic performance for cognition function without interaction.

Conclusions: A declining BMI trend and high variation in late-middle age were associated with a higher risk of dementia. Early monitoring of these individuals is needed to prevent dementia in older individuals.

Keywords: Body mass index; Dementia; Genetic performance; Population-based cohort study.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The association between BMI trajectories and risk of dementia stratified by mean BMI groups. Models were adjusted for sex, ethnicity, levels of education, year of age 65, marital status, smoking status, alcohol consumption status, history of medical conditions, and mean BMI group
Fig. 2
Fig. 2
The association between BMI trajectories and dementia risk stratified by PGS. Models were adjusted for sex, levels of education, year of age 65, marital status, smoking status, alcohol consumption, history of medical conditions, mean BMI group, and PC1-5. PGS: polygenetic score

Similar articles

Cited by

References

    1. International AD, University M . World Alzheimer Report 2021. London: Alzheimer’s Disease International; 2021.
    1. Vetrano DL, Rizzuto D, Calderón-Larrañaga A, Onder G, Welmer A-K, Bernabei R, et al. Trajectories of functional decline in older adults with neuropsychiatric and cardiovascular multimorbidity: a Swedish cohort study. PLoS Med. 2018;15:e1002503. doi: 10.1371/journal.pmed.1002503. - DOI - PMC - PubMed
    1. Beard JR, Offi A, De CIA, Sadana R, Pot AM, Michel J, et al. The World report on ageing and health : a policy framework. The Lancet. 2015;6736:1–10.
    1. Grande G, Qiu C, Fratiglioni L. Prevention of dementia in an ageing world : evidence and biological rationale. Ageing Res Rev. 2020;64:101045. doi: 10.1016/j.arr.2020.101045. - DOI - PubMed
    1. van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer’s disease. N Engl J Med. 2023;388:9–21. doi: 10.1056/NEJMoa2212948. - DOI - PubMed

Publication types